Arrowhead Pharmaceuticals, Inc.

NASDAQ:ARWR

20.78 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997
Operating Activities:
Net Income -209.275-176.494-140.848-84.55367.975-54.45-34.38-81.723-91.941-58.63-31.1430-8.785-6.201-19.308-27.089-29.931-18.997-6.625-2.497-0.095-0.246-0.186-0.1380.593-0.052-0.855
Depreciation & Amortization 12.49310.4218.2675.9424.4394.6994.693.262.3361.3461.7511.7490.2680.6550.9951.1331.0040.8870.6440.07500.0090.0040.0080.0080.0180.104
Deferred Income Tax -34.4080000-0.432-0.892.352-2.8888.0937.692-0.5761.549-0.014-1.34900-1,371.110-0.1430000000
Stock Based Compensation 78.13120.89376.67343.38312.3938.4557.89211.59610.2335.6961.5361.2411.3771.5822.676001,369.47800.1430000000
Change In Working Capital -51.547-98.293226.866-60.68987.159-5.878-1.2075.7183.4085.0050.140.2160.007-0.996-0.825-0.2330.0411.3550.4440.042-0.0620.1830.1520.0490.064-0.0130.088
Accounts Receivables 1.418.845-9.409-0.184-0.334-0.260.007-0.07500.075-0.066162.85500-60.65800-40.7660-0.0520000000
Inventory -3.36209.1621.602-1.261.3362.413-1.8930-139.436-20.235-162.9070060.01700-328.2960-8.9620-0.0070.0060.0020.002-0.0010.025
Accounts Payables 32.998-6.5892.628-0.8214.844-1.27-3.512.5552.4981.4120.3220.2920.157-0.332-0.32900370.36500.2480000000
Other Working Capital -82.593-100.549224.485-61.28683.909-5.683-0.1175.1310.91142.95420.119-0.024-0.15-0.6650.145-0.2330.0410.0530.4448.807-0.0620.190.1460.0470.062-0.0120.063
Other Non Cash Items 50.7177.3420.2660.5251.0690.383-0.044-5.63113.1453.0740.99-17.9710.194-2.7252.534-1.3965.023.596-3.5620.0660-0.052-0.0520.001-0.70100.667
Operating Cash Flow -153.89-136.131171.224-95.392173.035-47.223-23.939-64.427-65.708-35.416-19.033-15.34-5.391-7.699-15.277-27.585-23.867-14.791-9.099-2.314-0.158-0.106-0.082-0.08-0.035-0.0460.005
Investing Activities:
Investments In Property Plant And Equipment -176.737-52.777-23.567-11.952-12.001-1.421-7.918-3.86-1.971-1.717-0.297-0.48-0.01-0.005-0.04-0.684-0.756-0.935-0.673-0.665-0.002-0.0020-0.001000
Acquisitions Net -80.582-47.36141.678240,777.76447,746.0077,434.96300-10000.121-1.7000.1095.136205.067-8.0010.3060000000
Purchases Of Investments -246.141-223.391-240.703-278.964-90.266-52.083-44.97500-46.366-10.73301,700.3980000-18.5762.42500000000
Sales Maturities Of Investments 326.723270.751122.59250.13854.52146.0694.24917.30826.09111.5911.4190.5091.53500.70018.9680.4900000000
Other Investing Activites 80.58247.36-141.678-240,777.764-47,746.007-7,434.963-40.72617.3080.0010.010.090.29-1,700.3980.4930.079-20-205.0678.0280.3060000000
Investing Cash Flow -96.155-5.417-141.678-240.778-47.746-7.435-48.64413.44814.121-36.482-9.5210.441-0.1750.4880.739-2.5754.38-0.5422.269-0.36-0.002-0.0020-0.001000
Financing Activities:
Debt Repayment -250000-2.415-0.209-0.198-0.218-0.214-0.225-0.215-0.1970-0.727-0.81000000000-0.0010-0.004
Common Stock Issued 3.0535.18611.305250.47960.52260.16212.25355.9840172.64244.50610.9666.22612.1654.75916.27315.58720.88720.7449.8710.005000000
Common Stock Repurchased 00000-0.055-0.439-0.6340000000000000000000
Dividends Paid 000000000000000000000000000
Other Financing Activities 253.0536011.3057.4698.27560.21612.69255.9840.50512.87844.50610.774,507.3890.62.516-0.1400001.510.1260.080.0830.0350.0460
Financing Cash Flow 253.05365.18611.305257.94866.38259.95312.05555.1320.291185.29444.29110.776.22612.0396.46516.13315.58720.88720.7449.8711.5150.1260.080.0830.0340.046-0.004
Other Information:
Effect Of Forex Changes On Cash -0.122-0.067-0.0880.41000000000000000-1.3550000000
Net Change In Cash 2.886-76.42940.851-78.221191.6715.295-60.5284.152-51.296113.39615.737-4.130.664.827-8.073-14.027-3.95.55313.9145.8421.3550.018-0.0020.002-0.001-00
Cash At End Of Period 110.891108.005184.434143.583221.80430.13324.83985.36681.214132.51119.1143.3777.5076.8472.0210.09424.1228.0222.4677.1971.3550.01800.00200.0010.001